---
document_datetime: 2023-09-21 17:54:09
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/hyqvia-epar-all-authorised-presentations_en.pdf
document_name: hyqvia-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0691045
conversion_datetime: 2025-12-18 09:08:47.612456
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size       |
|-----------------|-------------------|------------|-----------------------|---------------------------|----------------------------|---------------------------|-----------------|
| EU/1/13/840/001 | HyQvia            | 100 mg/ml  | Solution for infusion | Subcutaneous use          | vial (glass); vial (glass) | 25 ml; 1.25 ml            | 1 vial + 1 vial |
| EU/1/13/840/002 | HyQvia            | 100 mg/ml  | Solution for infusion | Subcutaneous use          | vial (glass); vial (glass) | 50 ml; 2.5 ml             | 1 vial + 1 vial |
| EU/1/13/840/003 | HyQvia            | 100 mg/ml  | Solution for infusion | Subcutaneous use          | vial (glass); vial (glass) | 100 ml; 5 ml              | 1 vial + 1 vial |
| EU/1/13/840/004 | HyQvia            | 100 mg/ml  | Solution for infusion | Subcutaneous use          | vial (glass); vial (glass) | 200 ml; 10 ml             | 1 vial + 1 vial |
| EU/1/13/840/005 | HyQvia            | 100 mg/ml  | Solution for infusion | Subcutaneous use          | vial (glass); vial (glass) | 300 ml; 15 ml             | 1 vial + 1 vial |